Northwest Biotherapeutics Inc (OTCQB:NWBO)

0.3279
Delayed Data
As of 2:57pm ET
 +0.0021 / +0.66%
Today’s Change
0.14
Today|||52-Week Range
0.43
+39.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues71.0K68.0K88.0K148.0K
 
 
 
 
 
Depreciation And Amortization54.0K56.0K44.0K41.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses21.3M11.9M10.7M14.2M
 
 
 
 
 
Research And Development16.8M5.0M5.5M9.7M
 
 
 
 
 
Total Operating Expenses21.3M12.0M10.8M14.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.2M-11.9M-10.7M-14.1M
 
 
 
 
 
Extraordinary Credit653.0K1.4M6.5M0.00
 
 
 
 
Extraordinary Charge-6.4M-1.5M-7.0M-9.2M
 
 
 
 
 
Interest Expense On Debt1.7M1.2M1.3M1.2M
 
 
 
 
 
Other Expenses-2.0M574.0K2.3M1.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-30.7M-12.6M-10.3M-23.3M
 
 
 
 
 
Net Income-30.7M-12.6M-10.3M-23.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS122.8M161.5M208.5M281.5M
 
 
 
 
 
Shares To Calculate EPS Diluted122.8M161.5M208.5M281.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.25-$0.08-$0.05-$0.08
 
 
 
 
 
EPS Diluted-$0.25-$0.08-$0.05-$0.08